Navigation Links
Quintiles to Open Clinical Research Office in Wilmington, NC
Date:1/17/2008

Growth driving second new office opening in North Carolina in last 12

months

RESEARCH TRIANGLE PARK, N.C., Jan. 17 /PRNewswire/ -- Quintiles Transnational Corp. today announced that the global leader in pharmaceutical services will open an office in Wilmington, N.C. The new office is an expansion of Quintiles' clinical research in pharmaceutical and biotechnology development.

The new Wilmington office is Quintiles' second expansion within the state in the last 12 months. Last January, Quintiles opened a data processing center in Williamston, N.C.

"With a strong educational system and a positive environment for business, North Carolina is clearly the leading location for global clinical research organizations," said Mike Mortimer, Executive Vice President and Chief Administrative Officer. "We were founded in the Research Triangle more than 25 years ago, and we've fueled our growth by tapping into an excellent work force like that in North Carolina, with people committed to improving health care around the world. Our employees find Quintiles to be a place for fulfilling, rewarding work and in return they are driving the company to great success."

The Wilmington office is centrally located in the North State Bank Building, 1411 Commonwealth Drive, convenient to major thoroughfares and the Wilmington airport, and not far from Wrightsville Beach. Quintiles will occupy two of the three stories of the bank building.

Founded in 1982 by current CEO and Chairman Dennis Gillings, CBE, the company is considered a pioneer in clinical research. Quintiles is the largest provider of pharmaceutical services in the world, with more than 19,000 employees in more than 50 countries. More than 1,500 are employed in North Carolina.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With more than 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.quintiles.com.


'/>"/>
SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
2. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
3. Expert Cardiologist Joins Quintiles Medical Group
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. YM BioSciences provides update on AeroLEF(TM) clinical development program
6. Irving Dark Named Vice President of Cytel Clinical Research Services
7. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
8. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
9. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
10. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
11. Association of Clinical Research Organizations (ACRO) Elects New Officers for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
Breaking Biology News(10 mins):